Finance

Lists
NAGE:NASDAQ
Niagen Bioscience Inc
2,58 $
-1,90%
(-0,050) 1D
2,58 $
0,00% (0,00)
After hours
Closed: 13 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAGE...
Open
2,63 $
High
2,64 $
Low
2,55 $
Mkt. cap
205,76 մլն
Avg. vol.
476,87 հզր
Volume
530,56 հզր
52-wk high
7,95 $
52-wk low
2,55 $
Beta
2,02
Shares outstanding
79,13 մլն
No. of employees
117
Open
2,63 $
High
2,64 $
Low
2,55 $
Mkt. cap
205,76 մլն
Avg. vol.
476,87 հզր
Volume
530,56 հզր
52-wk high
7,95 $
52-wk low
2,55 $
Beta
2,02
Shares outstanding
79,13 մլն
No. of employees
117
News stories
From web sources and news partners
Profile
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
About Niagen Bioscience Inc
CEO-
Employees117
Founded1999
HeadquartersԼոս Անջելես, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorPersonal care products
Analyst ratings
Based on 4 analysts giving stock ratings to NAGE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NAGE in the last 3 months.
Highest
Current 2,58 $
11,00 $ (+326,36%)
Average
10,50 $ (+306,98%)
Lowest
10,00 $ (+287,60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean McGowan
Roth MKM
Buy
Maintained
10,00 $
+287,6%
10/12/2026
Susan Anderson
Canaccord Genuity
Buy
Reiterated
10,00 $
+287,6%
10/05/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
11,00 $
+326,4%
08/05/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Maintained
11,00 $
+326,4%
07/21/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
9,00 $
+248,8%
07/06/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
12,00 $
+365,1%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
33,99 մլն
33,84 մլն
31,47 մլն
29,78 մլն
Cost of goods sold
12,06 մլն
12,14 մլն
11,50 մլն
10,47 մլն
Cost of revenue
12,06 մլն
12,14 մլն
11,50 մլն
10,47 մլն
Research and development expenses
1,80 մլն
1,71 մլն
1,48 մլն
1,51 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,90 մլն
17,89 մլն
16,92 մլն
17,10 մլն
Operating expense
17,69 մլն
19,60 մլն
18,40 մլն
18,61 մլն
Total operating expenses
29,75 մլն
31,74 մլն
29,90 մլն
29,08 մլն
Operating income
4,24 մլն
2,10 մլն
1,58 մլն
700,00 հզր
Other non operating income
-
-214,00 հզր
-
-
EBT including unusual items
4,80 մլն
4,42 մլն
6,74 մլն
1,07 մլն
EBT excluding unusual items
4,80 մլն
2,44 մլն
1,95 մլն
1,07 մլն
Income tax expense
222,00 հզր
292,00 հզր
417,00 հզր
106,00 հզր
Effective tax rate
4,62%
6,60%
6,19%
9,92%
Other operating expenses
-
-
-
-
Net income
4,58 մլն
4,13 մլն
6,32 մլն
963,00 հզր
Net profit margin
13,47%
12,21%
20,07%
3,23%
Earnings per share
0,05
0,03
0,02
0,01
Interest and investment income
564,00 հզր
552,00 հզր
375,00 հզր
372,00 հզր
Interest expense
-
-
-
-
Net interest expenses
564,00 հզր
552,00 հզր
375,00 հզր
372,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
4,43 մլն
2,30 մլն
1,87 մլն
991,00 հզր
Gain or loss from assets sale
-
-
-4,78 մլն
26,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps